The burden of disease caused by Staphylococcus aureus continues to grow; this organism has the ability to form biofilm and it is also a frequent cause of medical device and implant-related infections. The objective of this study was to evaluate the biofilm-forming ability of a collection of clinical isolates of S. aureus. In a total of 240 Staphylococcus spp. isolated from catheters, retrieved at five services (neonatology, internal medicine, pneumology, pediatric and neurology), only 50 (20.83%) strains were identified by conventional microbiological methods as S. aureus species; these strains were screened by microtiter plate assay for detection of biofilm formation. Of the 50 clinical isolates, 16 (32%) were non adherent, 20(40%) weakly, 10 (20%) moderately and 4(8%) strongly adherent. The quantitative method of microtiter plate can be involved as a simple, rapid, inexpensive and reproducible assay to assess biofilm formation which is further an important feature of pathogenecity of S. aureus in the clinical setting.
No takes yet. Share an insight, caveat, or question.
Lotfi et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: